Renal Cancer - Results from #3380

Serum Lactate Dehydrogenase Before Nivolumab Treatment Could Be a Therapeutic Prognostic Biomarker for Patients With Metastatic Clear Cell Renal Cell Carcinoma. August 16, 2019

Identification of novel prognostic alternative splicing signature in papillary renal cell carcinoma. August 15, 2019

Lamin-B1 is a senescence-associated biomarker in clear-cell renal cell carcinoma. August 15, 2019

Integrative Analysis of Multi-Genomic Data for Kidney Renal Cell Carcinoma. August 15, 2019

MiT Family Translocation Renal Cell Carcinoma: from the Early Descriptions to the Current Knowledge. August 14, 2019

The Correlation of Clinicopathological Features With the Status of Surgical Margins in Renal Cell Cancer Patients Following Nephron-Sparing Surgery: A Systematic Review and Meta-Analysis. August 14, 2019

Clinical Efficacy and Complication Rate of Sunitinib 2/1 Versus 4/2 Schedule for the Treatment of Metastatic Renal Cell Cancer: A Systematic Review and Meta-Analysis. August 14, 2019

Feasibility of the ACL (albumin, C-reactive protein and lactate dehydrogenase) model as a novel prognostic tool in patients with metastatic renal cell carcinoma previously receiving first-line targeted therapy. August 13, 2019

Cabozantinib Versus Sunitinib for Untreated Patients with Advanced Renal Cell Carcinoma of Intermediate or Poor Risk: Subgroup Analysis of the Alliance A031203 CABOSUN trial. August 13, 2019

Defining Risk Categories for a Significant Decline in Estimated Glomerular Filtration Rate After Robotic Partial Nephrectomy: Implications for Patient Follow-up August 13, 2019

Dose-response relationships between cigarette smoking and kidney cancer: A systematic review and meta-analysis. August 12, 2019

Baseline perfusion CT parameters as potential biomarkers in predicting long-term prognosis of localized clear cell renal cell carcinoma. August 12, 2019

Comparison of survival benefits of nephron-sparing intervention or active surveillance for patients with localized renal masses: a systematic review and meta-analysis. August 12, 2019

DYSF expression in clear cell renal cell carcinoma: A retrospective study of 2 independent cohorts. August 9, 2019

Stereotactic Ablative Radiotherapy (SAbR) Used to Defer Systemic Therapy in Oligometastatic Renal Cell Cancer. August 9, 2019

Sunitinib rechallenge in advanced renal cell carcinoma: outcomes of a multicenter retrospective study. August 9, 2019

Familial Kidney Cancer: Implications of New Syndromes and Molecular Insights. August 8, 2019

Prognostic value of pretreatment neutrophil count in metastatic renal cell carcinoma: a systematic review and meta-analysis. August 8, 2019

miR-142-3p as a novel biomarker for predicting poor prognosis in renal cell carcinoma patients after surgery. August 8, 2019

Urine Metabolomics for Renal Cell Carcinoma (RCC) Prediction: Tryptophan Metabolism as an Important Pathway in RCC. August 7, 2019

Page 170 of 456